Galenica AG
GALE.SW
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.96B
Close$
$96.37
12.7% upside
Current Fair Value
12.7% upsideUndervalued by 12.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.96 Billion |
|---|---|
| Enterprise Value | $6.04 Billion |
| Dividend Yield | $2.50 (2.93%) |
| Earnings per Share | $3.63 |
| Beta | 0.28 |
| Outstanding Shares | 49,889,473 |
Return
| Return on Equity | 24.89% |
|---|---|
| Return on Assets | 10.57% |
| Return on Invested Capital | 18.96% |
Valuation & Multiples
| P/E Ratio | 26.71 |
|---|---|
| PEG | -107.56 |
| Price to Sales | 0.52 |
| Price to Book Ratio | 3.05 |
| Enterprise Value to Revenue | 0.73 |
| Enterprise Value to EBIT | 13.96 |
| Enterprise Value to Net Income | 17 |
| Total Debt to Enterprise | 0.19 |
| Debt to Equity | 0.8 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$1.93
Average shareholder expectationRevenue Estimate
$2.13 B
Average shareholder expectationNext Earnings Call
Expected Date
March 9, 2027
EPS Estimate
$2.07
Average shareholder expectationRevenue Estimate
$2.24 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Galenica AG
6,558 employees
CEO: Marc Werner Galenica AG operates as a prominent healthcare services provider, delivering solutions across Switzerland and internationally. Its operations are structured into two core divisions: Products & Care, and Logistics & Information Technology...